Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10896123rdf:typepubmed:Citationlld:pubmed
pubmed-article:10896123lifeskim:mentionsumls-concept:C0684336lld:lifeskim
pubmed-article:10896123lifeskim:mentionsumls-concept:C0035203lld:lifeskim
pubmed-article:10896123lifeskim:mentionsumls-concept:C0521451lld:lifeskim
pubmed-article:10896123lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:10896123lifeskim:mentionsumls-concept:C0007996lld:lifeskim
pubmed-article:10896123lifeskim:mentionsumls-concept:C1154437lld:lifeskim
pubmed-article:10896123lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:10896123lifeskim:mentionsumls-concept:C0077436lld:lifeskim
pubmed-article:10896123lifeskim:mentionsumls-concept:C0260049lld:lifeskim
pubmed-article:10896123pubmed:issue6lld:pubmed
pubmed-article:10896123pubmed:dateCreated2000-12-6lld:pubmed
pubmed-article:10896123pubmed:abstractTextThe mammalian alkaloids tryptoline (1) and eleagnine (2) as well as the highly halogenated (X = F, Cl, Br) tetrahydro-beta-carbolines (THbetaCs) 3-5, structurally similar to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP, 6), were found to have a common feature of inducing a severe impairment of the nigrostriatal dopamine metabolism and inhibiting complex I of the mitochondrial respiratory chain highly selectively. Within the series of compounds tested, 1-tribromomethyl-1,2,3,4-tetrahydro-beta-carboline ('TaBro', 5), which was prepared in high yields from the biogenic amine tryptamine ('Ta', 7) and the unnatural aldehyde bromal ('Bro', 8) by a Pictet-Spengler cyclization reaction, turned out to be the most potent toxin in vitro and in vivo. As demonstrated by voltammetric measurements on rats, for all the THbetaCs 1-5 investigated, intranigral application of a single dose of 10 microg resulted in a significant reduction of the dopaminergic activity in the striatum, with the strongest effect being observed for TaBro (5). Using rat brain homogenates, again 5 (IC50 = 200 microM) as well as its dehydrohalogenation product 11 (IC50 = 150 microM) exhibited the most pronounced inhibitory potential on mitochondrial respiration. The halogen-free THbetaCs 1 and 2 as well as the MPTP metabolite 1-methyl-4-phenylpyridinium ion (MPP+), by contrast, showed only a moderate inhibition at concentrations in the millimolar range (e.g. for MPP+: IC50 = 3.5 mM). For an elucidation of the role of hydrophobic portion in the inhibitory action against complex I activity, several N-acyl derivatives (15-21) of 5 were synthesized and tested. An X-ray diffraction study on the 3-dimensional structure of trifluoroacetylated highly halogenated THbetaCs (12-14) revealed the tetrahydropyrido part to adopt a nearly planarized half-chair conformation. Because of the steric demand of the trihalogenmethyl moiety (CF3 < CCl3 < CBr3), the N-substituent is dramatically pushed out of that ring 'plane'.lld:pubmed
pubmed-article:10896123pubmed:languageenglld:pubmed
pubmed-article:10896123pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10896123pubmed:citationSubsetIMlld:pubmed
pubmed-article:10896123pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10896123pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10896123pubmed:statusMEDLINElld:pubmed
pubmed-article:10896123pubmed:monthJunlld:pubmed
pubmed-article:10896123pubmed:issn0968-0896lld:pubmed
pubmed-article:10896123pubmed:authorpubmed-author:PetersKKlld:pubmed
pubmed-article:10896123pubmed:authorpubmed-author:BrücknerRRlld:pubmed
pubmed-article:10896123pubmed:authorpubmed-author:WesemannWWlld:pubmed
pubmed-article:10896123pubmed:authorpubmed-author:GrossRRlld:pubmed
pubmed-article:10896123pubmed:authorpubmed-author:BlankMMlld:pubmed
pubmed-article:10896123pubmed:authorpubmed-author:BringmannGGlld:pubmed
pubmed-article:10896123pubmed:authorpubmed-author:ReichmannHHlld:pubmed
pubmed-article:10896123pubmed:authorpubmed-author:JanetzkyBBlld:pubmed
pubmed-article:10896123pubmed:authorpubmed-author:ClementH WHWlld:pubmed
pubmed-article:10896123pubmed:authorpubmed-author:FeineisDDlld:pubmed
pubmed-article:10896123pubmed:authorpubmed-author:PetersE MEMlld:pubmed
pubmed-article:10896123pubmed:issnTypePrintlld:pubmed
pubmed-article:10896123pubmed:volume8lld:pubmed
pubmed-article:10896123pubmed:ownerNLMlld:pubmed
pubmed-article:10896123pubmed:authorsCompleteYlld:pubmed
pubmed-article:10896123pubmed:pagination1467-78lld:pubmed
pubmed-article:10896123pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10896123pubmed:meshHeadingpubmed-meshheading:10896123...lld:pubmed
pubmed-article:10896123pubmed:meshHeadingpubmed-meshheading:10896123...lld:pubmed
pubmed-article:10896123pubmed:meshHeadingpubmed-meshheading:10896123...lld:pubmed
pubmed-article:10896123pubmed:meshHeadingpubmed-meshheading:10896123...lld:pubmed
pubmed-article:10896123pubmed:meshHeadingpubmed-meshheading:10896123...lld:pubmed
pubmed-article:10896123pubmed:meshHeadingpubmed-meshheading:10896123...lld:pubmed
pubmed-article:10896123pubmed:meshHeadingpubmed-meshheading:10896123...lld:pubmed
pubmed-article:10896123pubmed:meshHeadingpubmed-meshheading:10896123...lld:pubmed
pubmed-article:10896123pubmed:meshHeadingpubmed-meshheading:10896123...lld:pubmed
pubmed-article:10896123pubmed:meshHeadingpubmed-meshheading:10896123...lld:pubmed
pubmed-article:10896123pubmed:meshHeadingpubmed-meshheading:10896123...lld:pubmed
pubmed-article:10896123pubmed:meshHeadingpubmed-meshheading:10896123...lld:pubmed
pubmed-article:10896123pubmed:meshHeadingpubmed-meshheading:10896123...lld:pubmed
pubmed-article:10896123pubmed:year2000lld:pubmed
pubmed-article:10896123pubmed:articleTitleBromal-derived tetrahydro-beta-carbolines as neurotoxic agents: chemistry, impairment of the dopamine metabolism, and inhibitory effects on mitochondrial respiration.lld:pubmed
pubmed-article:10896123pubmed:affiliationInstitut für Organische Chemie, Universität Würzburg, Germany. bringman@chemie.uni-wuerzburg.delld:pubmed
pubmed-article:10896123pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10896123pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed